Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2003
10/01/2003EP1347967A1 Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists
10/01/2003EP1347966A1 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives
10/01/2003EP1347963A2 Benzofuran and benzothiophene derivatives as selective cox-2 inhibitors
10/01/2003EP1347959A1 Indole derivatives as ligands of thyroid receptors
10/01/2003EP1347950A1 Derivatives of 4-hydroxybutanoic acid and of its higher homologue as ligands of gamma-hydroxybutyrate (ghb) receptors, pharmaceutical compositions containing same and pharmaceutical uses
10/01/2003EP1347778A1 Behavior chemotherapy
10/01/2003EP1347767A1 Tahitian noni juice on cox-1 and cox-2 and tahitian noni juice as a selective cox-2 inhibitor
10/01/2003EP1347760A2 Nmda receptor agonist pharmaceutical compositions
10/01/2003EP1347755A2 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
10/01/2003EP1347751A2 Methods of treating bone cancer and the pain associated therewith using endothelin antagonists
10/01/2003EP1347748A2 Hydrostatic delivery system for controlled delivery of agent
10/01/2003EP1347746A1 Over-coated chewing gum formulations including tableted center
10/01/2003EP1347743A2 Composition for treatment of inflammatory disorders
10/01/2003EP1206472B1 Oxazole and thiazole derivatives as neurotrophin production/secretion promoting agent
10/01/2003EP1204655B1 A crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy] phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride
10/01/2003EP1202724B1 Method for treating chronic pain using mek inhibitors
10/01/2003EP1200447B1 Oxazinocarbazoles for the treatment of cns diseases
10/01/2003EP1105393B1 Bicyclic piperidine and piperazine compounds having 5-ht6 receptor affinity
10/01/2003EP1089996B1 Paroxetine methanesulfonate acetonitrile solvate 1:1
10/01/2003EP1051393B1 New derivatives of sulfonic, phosphonic and phosphinic aminoalkane acids, their production and their use as medicaments
10/01/2003EP1019434B1 Inhibitors of metalloproteinases, their therapeutic use, and process for the production of the starting compound in their synthesis
10/01/2003EP0977558B1 Use of 5ht4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhibitors
10/01/2003EP0966448B1 Pyrazine compounds
10/01/2003EP0944595B1 5-cyclo indole compounds as 5-ht1d receptor ligands
10/01/2003EP0662087B1 Method for purifying retinal pigmented epithelium derived neurotrophic factor
10/01/2003CN1446218A Benzimidazole derivatives, preparation method and therapeutic use thereof
10/01/2003CN1446216A Indole derivatives useful for treatment of CNS disorders
10/01/2003CN1446211A Indole derivatives useful for treatment of CNS disorders
10/01/2003CN1446202A 2-aminopyridine compounds and use thereof as drugs
10/01/2003CN1446197A Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
10/01/2003CN1446193A Aminoadamantane derivatives as therapeutic agents
10/01/2003CN1446108A Pharmaceutical form comprising a support material and at least a cell regulating factor and/or cell proliferation promoter
10/01/2003CN1446100A Method for treating movement disorder
10/01/2003CN1446097A Use of derivatives of valproic acid and 2-valproenic acid amides for treatment of mania in bipolar disorder
10/01/2003CN1446089A Pharmaceutical composition containing citalopram
10/01/2003CN1446082A ÔÇ£Slow releaseÔÇØ pharmaceutical compositions comprising lithium carbonate
10/01/2003CN1446081A 神经毒素植入物 Neurotoxin implants
10/01/2003CN1445235A Anti-sense nucleic acid for stopping drug addiction
10/01/2003CN1445226A New cornpound derivated from quinazoline, itd preparation method and medicinal composite containig them
10/01/2003CN1445221A Pharmaceutical application of derivant of benzofuran-ketone
10/01/2003CN1444991A Preparing method and usage of cardiotoxin
10/01/2003CN1444985A Oil for comforting channels and collaterals
10/01/2003CN1444972A Chinese herbal medicine for treating epilepsia
10/01/2003CN1444968A Drug for treating sciatica and its preparing method
10/01/2003CN1444964A Application of ÔÇÿWurenchunÔÇÖ capsule for preparing medicine of treating sleep disorder
10/01/2003CN1444943A Pentoxifylline tablet controlled relasease tablet
10/01/2003CN1444942A 偏头痛治疗药 Migraine therapeutic agent
10/01/2003CN1444931A Aceglutamide injection
10/01/2003CN1444930A New usage of agmatine
10/01/2003CN1122718C Botulinum toxin derivatives able to modify peripheral sensory afferent functions
10/01/2003CN1122670C Thiazolobenzoheterocycles, prepn method and medicines containing same
10/01/2003CN1122666C New 2,3-dioxide indanol compounds, process for their preparation and pharmaceutical compositions containing them
10/01/2003CN1122522C Medicine for treating dipression mental diseases
10/01/2003CN1122517C Capsule for treating epilepsy
10/01/2003CN1122513C Use of compound in medicine for preparation of inhibiting pathological conditions
09/2003
09/30/2003US6627771 4-Amino-3-cyclopentylbutyric acid; antiepileptic, anxiolytic, antidepressant, analgesic, and antiinflammatory agents; brain, neurodegenerative, nervous system, psychological, and gastrointestinal disorders
09/30/2003US6627754 Pyrrolo[2,3-d]pyrimidine compounds
09/30/2003US6627739 Antibodies having preferential binding to proteases; screening for enzyme inhibitors used in therapy of neurodegenerative diseases, such as Alzheimer's disease
09/30/2003US6627661 Use of 5HT-6 antagonists
09/30/2003US6627659 Methods of decreasing the effects of oxidative stress in patients undergoing hemodialysis by intravenously administering N-acetylcysteine or a pharmaceutically acceptable salt thereof to the patient.
09/30/2003US6627656 Method of treatment using phenyl and biaryl derivatives as prostaglandin E inhibitors and compounds useful therefore
09/30/2003US6627653 Anticonvulsant derivatives useful for the treatment of depression
09/30/2003US6627649 (2S)-1-((2R,3S)-5-chloro-3-(2-chlorophenyl)-1-(3,4 -dimethoxybenzenesulfonyl)-3-hydroxy-2,3-dihydro-1H-indole-2 -carbonyl)pyrrolidine-2-carboxamide, a selective V1a arginine vasopressin receptor antagonist, in combination with the
09/30/2003US6627645 Muscarinic agonists
09/30/2003US6627644 4-piperidinyl alkyl amine derivatives as muscarinic receptor antagonists
09/30/2003US6627637 I kappa B kinase inhibitors for treating various disorders including arthritis
09/30/2003US6627635 Method of preventing abuse of opioid dosage forms
09/30/2003US6627633 The compounds also are potent inhibitors of human cellular proliferation. As such, the compounds constitute pharmaceutical compositions with a pharmaceutically acceptable carrier. Such compounds are useful in inhibiting cellular
09/30/2003US6627631 Desoxypeganine and its pharmaceutically acceptable acid addition salts can be used in the treatment of alcoholism. Said substances are administered preferably in a continuous and controlled manner. The pharmaceutical administration form
09/30/2003US6627627 Aralkyl and aralkylidene heterocyclic lactams and imides
09/30/2003US6627626 Antiinflammation agents and antiarthritic agents colon cancer, and Alzheimer's disease in mammals, preferably humans, dogs, cats and livestock animals.
09/30/2003US6627625 Beta-lactam antibiotics and beta -lactamase inhibitors provides significant neurotropic effects in warm-blooded vertebrates evidenced inter by anxiolytic and antiaggressive behavior modification ans enhanced cognition
09/30/2003US6627624 Agonists, antagonists or inverse agonists for GABAa brain receptors or prodrugs of agonists, antagonists or inverse agonists for GABAa brain receptors, and are therefore useful in the diagnosis and treatment of anxiety, Down Syndrome,
09/30/2003US6627602 Preventing desensitization of receptors
09/30/2003US6627601 Amino acid sequences derived partially from ependymin that binds with calcium; stroke and other neurodegenerative diseases; antiischemic agents; cognition activators; conjugated to transfer through blood-brain barrier
09/30/2003US6627405 53BP2 complexes
09/30/2003US6627214 Adding fumaric acid to reduce throat burn sensation
09/30/2003US6627211 Vehicle containing alcohol, glycol and biological surfactant
09/30/2003US6627195 Binding agents to CD23
09/30/2003CA2254750C Inhibition of matrix metalloproteases by 2-(.omega.-aroylalkyl)-4-biaryl-oxobutyric acids
09/30/2003CA2245768C Methods for treating emesis and central nervous system disorders using optically pure (+) norcisapride
09/30/2003CA2112982C Process for the preparation of optical isomers of a amino-2-napththyridine derivative
09/30/2003CA2112980C Process for the preparation of the dextrogyral isomer of a isoindolinone derivative
09/30/2003CA2112979C Novel derivative of amino-2-naphthyridine, preparation and use thereof
09/30/2003CA2102697C Pyrrolidine derivatives, preparation thereof and drugs containing same
09/30/2003CA2041579C Dosage form
09/25/2003WO2003080867A1 Novel primers for screening schizophrenia and a method thereof
09/25/2003WO2003079025A2 Methods for the identification of compounds useful for the suppression of chronic neuropathic pain and compositions thereof
09/25/2003WO2003078658A2 Methods for diagnosing and treating schizophrenia
09/25/2003WO2003078633A1 POLYPEPTIDES BINDING TO HUMAN SYNTAXIN 1a
09/25/2003WO2003078632A1 Novel receptor polypeptides and polynucleotides encoding the same
09/25/2003WO2003078623A1 Functional molecule and process for producing the same
09/25/2003WO2003078441A1 Aminomethyl-substituted thiazolobenzimidazole derivative
09/25/2003WO2003078437A1 Methods and compositions comprising nitric oxide donors and opioid analgesics
09/25/2003WO2003078435A1 Pyrazolo(1,5-a)pyridine derivatives as neurotransmitter modulators
09/25/2003WO2003078433A1 Process for preparing crystalline form i of cabergoline
09/25/2003WO2003078431A1 Aza-bicyclic n-biarylamides with affinity for the alpha-7 nicotinic acetylcholine receptor
09/25/2003WO2003078430A1 Amides of acetic and propionic acids
09/25/2003WO2003078428A1 Difurylglycolic acid tropenol esters used as anticholinesterase drugs
09/25/2003WO2003078425A1 Novel crystalline form of 5-[4-[[3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl]methoxy]benzyl]thiazolidine-2,4-dione potassium salt
1 ... 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 ... 1833